Validating pertussis data measures using electronic medical record data in Ontario, Canada 1986–2016

•Data measures used for pertussis research were validated using a cohort-selected design.•Diagnosis and documentation issues were found to seriously limit data accuracy.•To maximize case detection, use multiple data sources including electronic medical records.•Strategies targeting clinical diagnost...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine: X 2023-12, Vol.15, p.100408-100408, Article 100408
Hauptverfasser: McBurney, Shilo H., Kwong, Jeffrey C., Brown, Kevin A., Rudzicz, Frank, Chen, Branson, Candido, Elisa, Crowcroft, Natasha S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Data measures used for pertussis research were validated using a cohort-selected design.•Diagnosis and documentation issues were found to seriously limit data accuracy.•To maximize case detection, use multiple data sources including electronic medical records.•Strategies targeting clinical diagnostic practice are needed to improve case identification.•Better detection of older, milder cases with immunization history would reduce ascertainment bias. Pertussis is a reportable disease in many countries, but ascertainment bias has limited data accuracy. This study aims to validate pertussis data measures using a reference standard that incorporates different suspected case severities, allowing for the impact of case severity on accuracy and detection to be explored. We evaluated 25 pertussis detection algorithms in a primary care electronic medical record database between January 1, 1986 and December 30, 2016. We estimated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). We used sensitivity analyses to explore areas of uncertainty and evaluated reasons for lack of detection. The algorithm including all data measures achieved the highest sensitivity at 20.6%. Sensitivity increased to 100% after reclassifying symptom-only cases as non-cases, but the PPV remained low. Age at first episode was significantly associated with detection in half of the tested scenarios, and false negatives often had some history of immunization. Sensitivity improved by reclassifying symptom-only cases but remained low unless multiple data sources were used. Results demonstrate a trade-off between PPV and sensitivity. EMRs can enhance detection through patient history and clinical note data. It is essential to improve case identification of older individuals with vaccination history to reduce ascertainment bias.
ISSN:2590-1362
2590-1362
DOI:10.1016/j.jvacx.2023.100408